Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 1054, pseudogene (RNU6-1054P)** is a *processed pseudogene* derived from the U6 small nuclear RNA sequence family, notable for its presence in the human genome as a non-functional, non-coding genetic element[6]. U6 snRNAs are short, highly conserved RNA molecules that serve as core components of the spliceosome complex, essential for pre-mRNA splicing in eukaryotes[3][1]. However, pseudogenes such as RNU6-1054P do not produce functional RNA, as they lack necessary regulatory elements or contain disabling mutations. The formation of U6 snRNA pseudogenes is primarily driven by retrotransposon-mediated mechanisms, often involving LINE-1 elements and template switching events, resulting in occasional chimeric inserts in the genome[6]. Pseudogenes like RNU6-1054P serve no direct physiological function, do not act as therapeutic targets, and are mainly studied in the context of genome evolution or as potential molecular markers of retrotransposition activity[6]. **Note:** - RNU6-1054P is *not* a receptor, enzyme, transporter, or therapeutic target. - Its function is limited to being a non-coding genomic marker, not a protein or drug target. - Misinterpretation as a therapeutic target or functional molecule would be incorrect, hence `is_incorrect: true`. - No biological, disease, drug, or mechanistic associations are established for pseudogenes of this type.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1054, pseudogene (RNU6-1054P).